Morgan Stanley Call 600 GS 21.03..../ DE000MG0X7D8 /
2024-06-06 10:08:59 AM | Chg.-0.030 | Bid2:11:03 PM | Ask2:11:03 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.530EUR | -5.36% | 0.550 Bid Size: 750 |
0.620 Ask Size: 750 |
Goldman Sachs Group ... | 600.00 USD | 2025-03-21 | Call |
GlobeNewswire
2:00 PM
Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
1:00 PM
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:53 AM
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
06-05
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
GlobeNewswire
02-23
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Busines...
GlobeNewswire
2023-10-26
New to The Street's Leadership Series Airs Two Interviews, Sam Reese, CEO, Vistage Worldwide, Inc., ...